Login
Navigate Fool.com
Will CELG beat
the market?

Celgene

NASDAQ: CELG

Community Rating: 4 Stars: Favorite

141.86 2.02 (1.44%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $141.36
Previous Close $139.84
Daily Range $139.44 - $143.72
52-Week Range $110.53 - $174.66
Market Cap $57.6B
P/E Ratio 41.50
Dividend (Yield) $0.00 (0.0%)
Volume 3,820,626
Average Daily Volume 4,515,726
Current FY EPS $6.34

How do you think CELG
will perform against the market?

Top CELG Bull/Bear Pitches

 

Jeffreyw (< 20)
Submitted October 25, 2010

Big investment in discovery and production of new therapies. Monitizing these treatments will take time, but could be huge.

0 Replies Reply Report this Post
 

NetscribeBiotech (< 20)
Submitted February 22, 2007

Celgene is a biopharmaceutical company focused on novel therapies to treat a broad range of hematopoietic, immunological, neuronal, and cancerous conditions. Celgene currently markets Thalomid for EN … More

1 Replies Reply Report this Post

News & Commentary

The S&P 500's 3 Biggest Biotech Losers of 2014

It's been a rough year for biotech, especially for these three S&P 500 stocks.

3 Biotech Opportunities Following This Selloff

Here's a second chance to invest in companies with viable growth potential.

Health Care Stocks: Check Out This Low-Cost Market Beater

These health care stocks have been growing by double digits. Should you buy?

3 Humongous Health-Care Stocks This Week

The bubbles of some biotechs look to be floating up in the air instead of bursting. These three health-care stocks enjoyed humongous gains this week.

Are Celgene and Amgen Undervalued By the Market?

Celgene (CELG) and Amgen (AMGN) shares have fallen as investors have shifted away from biotech, but that may not mean they're cheap yet.

Tech stock rout continues in Asia

Asia tech stocks fall into the red

Stocks: Wall Street wears red

Who Bucked the Short Interest Trend in Biotech Stocks?

3 Stocks to Get on Your Watchlist

A cheap global automaker, a clinical-stage biopharmaceutical company with intriguing early-stage results, and a potentially overvalued weight-control company are this week's must-watch stocks.

Nasdaq 100 Movers: ISRG, REGN

See More CELG News...

Sector

Healthcare

Industry

Drugs

Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website: http://www.celgene.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks